The University of Chicago Header Logo

Connection

Sonali Smith to Rituximab

Back to Details
This is a "connection" page, showing publications Sonali Smith has written about Rituximab.
Sonali Smith
Connection Strength
0.850
Rituximab
  1. Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182.
    View in: PubMed
    Score: 0.555
  2. Too much and not enough: revisiting maintenance rituximab in indolent lymphomas. Haematologica. 2022 02 01; 107(2):353-354.
    View in: PubMed
    Score: 0.195
  3. Maintenance rituximab revisited: is it worth the cost? Leuk Lymphoma. 2012 Dec; 53(12):2331-2.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.